Pharmaceutical News

RSS

Catalent licenses NJIT’s taste-making technology to mask unpleasant and bitter medicines

Following a successful research collaboration with NJIT, Catalent Pharma Solutions of Somerset has announced that it has exclusively licensed innovative taste-making technology developed by NJIT Distinguished Professor Rajesh Dav-, who was the principal investigator of a research project funded by Catalent. The technology will mask the most challenging, unpleasant and bitter tasting pharmaceutical active ingredients.

11 Oct 2012

Older adults do not tend to adhere to their prescribed drugs after heart attack

Older adults who have had a heart attack don't tend to adhere to their prescribed drugs according to a new study of Medicare beneficiaries by the University of Maryland School of Pharmacy.

11 Oct 2012

Researchers develop interference therapies to knock down gene that drives MCL

Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed.

From Integrated DNA Technologies 11 Oct 2012

New drug candidate improves cognitive function of rats with Alzheimer's-like mental impairment

Washington State University researchers have developed a new drug candidate that dramatically improves the cognitive function of rats with Alzheimer's-like mental impairment.

11 Oct 2012

No link between HPV vaccination and increased sexual activity in adolescent girls

A study published in Vaccine reveals that contrary to recent discussions, the HPV vaccination does not increase sexual activity in adolescent girls.

10 Oct 2012

MSF launches online 'Patent Opposition Database'

"The international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) has launched an online resource to help civil society and patient groups in developing countries challenge unwarranted drug patents," an MSF press release reports.

10 Oct 2012

Keynote speaker on reimbursement for new medicines

Delegates at the largest annual biotech industry gathering in the Asia-Pacific will hear about delays to new medical treatments because of the slow processing of government funding approvals. In many countries, governments pay at least part of the cost of medicines and treatments. However, there is growing concern that delays in funding decisions could mean fewer new medicines are developed in the future.

10 Oct 2012

PARP-1 plays a major role in controlling AR function in prostate cancer patients

A newly discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent preclinical study published in Cancer Discovery by Jefferson's Kimmel Cancer Center researchers suggests.

10 Oct 2012

Chemotherapy plus immunotherapy can enhance anti-tumor effects in patients with advanced cancer

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.

10 Oct 2012

Pakistan to become first south Asian country to introduce pneumococcal vaccine

"Pakistan is set to become the first country in south Asia to introduce the pneumococcal vaccine to protect children against pneumonia, one of the biggest killers of children under five in the developing world," the Guardian reports.

10 Oct 2012

NACA could prevent or cure cataracts, macular degeneration and other eye conditions

Researchers at Missouri University of Science and Technology are working with an antioxidant that could prevent or cure cataracts, macular degeneration and other degenerative eye disorders.

10 Oct 2012

Mylan, Shionogi and CIMA Labs to resolve generic Orapred ODT patent litigation

Mylan Inc. today announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, 15 mg and 30 mg.

10 Oct 2012

Researchers discover mechanism by which magnesium reduces cytokine production

Magnesium sulfate is given to many pregnant women to treat preterm labor and preeclampsia and was recently shown to prevent cerebral palsy; however little is known about how it works. Researchers at Case Western Reserve University School of Medicine recently discovered the mechanism by which magnesium reduces the production of cytokines.

10 Oct 2012

Anesthetic-loaded liposomes can delay onset of neuropathic pain

Using tiny spheres filled with an anesthetic derived from a shellfish toxin, researchers at Boston Children's Hospital and the Massachusetts Institute of Technology have developed a way to delay the rise of neuropathic pain, a chronic form of pain that arises from flawed signals transmitted by damaged nerves.

10 Oct 2012

QRxPharma, Paladin execute licensing agreement for MOXDUO

QRxPharma Limited announced today execution of a licensing agreement with Paladin Labs Inc. for the Canadian commercialisation rights to MOXDUO, a patented, immediate release formulation of morphine and oxycodone.

10 Oct 2012

AFPE, AAPS enter new strategic alliance to advance pharmaceutical science education

The American Association of Pharmaceutical Scientists (AAPS) and the American Foundation for Pharmaceutical Education (AFPE) have entered into an exciting new strategic alliance to advance support for pharmaceutical science education.

10 Oct 2012

Aspirin associated with reduced risk of serious ovarian cancer

New research shows that women who regularly use pain relief medications, particularly aspirin, have a decreased risk of serious ovarian cancer—an aggressive carcinoma affecting the surface of the ovary.

10 Oct 2012

Pieris achieves milestone in Anticalin discovery and development collaboration with Daiichi Sankyo

Pieris AG announced today the achievement of the first financial milestone in its discovery and development collaboration with Daiichi Sankyo Company Limited.

9 Oct 2012

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Working with individuals with traumatic brain injury (TBI) every day, I see the debilitating effects and long-term struggles firsthand.

9 Oct 2012

Financial Times examines use of financial transaction taxes to raise development funds

The Financial Times examines the creation of UNITAID, an innovative financing mechanism and international drug purchasing facility, and how Philippe Douste-Blazy, chair of the UNITAID Executive Board and France's former foreign minister who helped create the organization, is looking to move beyond drug financing to raise money through "microdonations" for development programs.

9 Oct 2012

Pharmaceutical News

Catalent licenses NJIT’s taste-making technology to mask unpleasant and bitter medicines

Older adults do not tend to adhere to their prescribed drugs after heart attack

Researchers develop interference therapies to knock down gene that drives MCL

New drug candidate improves cognitive function of rats with Alzheimer's-like mental impairment

No link between HPV vaccination and increased sexual activity in adolescent girls

MSF launches online 'Patent Opposition Database'

Keynote speaker on reimbursement for new medicines

PARP-1 plays a major role in controlling AR function in prostate cancer patients

Chemotherapy plus immunotherapy can enhance anti-tumor effects in patients with advanced cancer

Pakistan to become first south Asian country to introduce pneumococcal vaccine

NACA could prevent or cure cataracts, macular degeneration and other eye conditions

Mylan, Shionogi and CIMA Labs to resolve generic Orapred ODT patent litigation

Researchers discover mechanism by which magnesium reduces cytokine production

Anesthetic-loaded liposomes can delay onset of neuropathic pain

QRxPharma, Paladin execute licensing agreement for MOXDUO

AFPE, AAPS enter new strategic alliance to advance pharmaceutical science education

Aspirin associated with reduced risk of serious ovarian cancer

Pieris achieves milestone in Anticalin discovery and development collaboration with Daiichi Sankyo

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Financial Times examines use of financial transaction taxes to raise development funds

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News